Thursday 24 November 2011

Tumor-Homing Peptide Delivers Treatment That Shrinks Tumors And Minimizes Side Effects

The trouble with most anti-cancer therapies is that they are lethal to most cells in the body, not just cancer cells. As a result, patients experience side effects like nausea, increased susceptibility to infection, and increased risk of developing secondary cancers later in life. Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) are developing techniques to deliver cancer drugs directly to tumors, increasing their effectiveness and decreasing collateral damage...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/AZ_5M9rqfNM/238054.php

news auto sport medical

No comments:

Post a Comment